Washington, District of Columbia, United States Related Funds
| Fund Name | Location |
| BlackSoil | India, Maharashtra, Mumbai |
| Clearance | - |
| Czech Venture Capital Association | Czech Republic, Prague, Prague |
| Everblu Capital | Australia, New South Wales, Sydney |
| EXTOREL | Bayern, Germany, Munich |
| Hamilton Ventures LLC | Atlanta, Georgia, United States |
| Hartwig | - |
| Imperial College Business School | England, London, United Kingdom |
| Institute for Systems Biology | Seattle, United States, Washington |
| Jiayi IEIG | - |
| Kereon Partners | Community of Madrid, Madrid, Spain |
| Oman India Joint Investment Fund | India, Maharashtra, Mumbai |
| Proterra Investment Partners | Minneapolis, Minnesota, United States |
| Radio Unica Communications | Florida, Miami, United States |
| the Way Forward Aps | - |
| TheVentures | Seoul, Seoul-t'ukpyolsi, South Korea |
| UCLA Ventures | California, Los Angeles, United States |
| Vuzix | New York, Rochester, United States |
| Yehe Investment | China, Chongming, Chongming District |
| Zanichelli Venture | Bologna, Emilia-Romagna, Italy |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
BugSeq Bioinformatics | 03 May 2022 | Vancouver, British Columbia, Canada | |||
Visby Medical | $25M | 22 Mar 2022 | San Jose, California, United States | ||
The Stevanato Group | $95M | 01 Mar 2022 | Veneto, Veneto, Italy | ||
Spero Therapeutics | $12M | 19 Jan 2022 | Cambridge, Massachusetts, United States | ||
Basilea Pharmaceutica | $4M | 16 Aug 2021 | Basel, Basel-Stadt, Switzerland | ||
Cepheid | $27M | 29 Jul 2021 | Sunnyvale, California, United States | ||
SeLux Diagnostics | $14M | 08 Jun 2021 | Boston, Massachusetts, United States | ||
Visby Medical | $12M | 02 Feb 2021 | San Jose, California, United States | ||
First Light Diagnostics | $4M | 27 Oct 2020 | Massachusetts, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data 
Get matched with relevant funds
